Relation of Patient Age and Mortality to Reported Contraindications to Early Beta-Blocker Use for Non-ST-Elevation Acute Coronary Syndrome

American Journal of Cardiology

Volumn 104, Issue 10, 2009, Pages 1324-1329

  Allen LaPointe, Nancy M ^a   Chen, Anita Y ^a   Roe, Matthew T ^a   Cohen, David J ^b   Diercks, Deborah B ^c   Hoekstra, James W ^d   Fesmire, Francis M ^e   Gibler, W Brian ^f   Ohman, E Magnus ^a   Peterson, Eric D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e ERLANGER HEALTH SYSTEM   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; DRUG CONTRAINDICATION; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; BRADYCARDIA; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; REGISTRIES; UNITED STATES;

EID: 71749085084     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.054     Document Type: Article

References (21)

1. Hoekstra J.W., Pollack Jr. C.V., Roe M.T., Peterson E.D., Brindis R., Harrington R.A., Christenson R.H., Smith S.C., Ohman E.M., and Gibler W.B. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med 9 (2002) 1146-1155
2. Liang K., and Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
3. Eagle K.A., Lim M.J., Dabbous O.H., Pieper K.S., Goldberg R.J., Van de Werf F., Goodman S.G., Granger C.B., Steg P.G., Gore J.M., Budaj A., Avezum A., Flather M.D., and Fox K.A. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
4. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304 (1981) 801-807
5. Hjalmarson A., Elmfeldt D., Herlitz J., Holmberg S., Málek I., Nyberg G., Rydén L., Swedberg K., Vedin A., Waagstein F., Waldenström A., Waldenström J., Wedel H., Wilhelmsen L., and Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet 2 (1981) 823-827
6. Beta-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247 (1982) 1707-1714
7. MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J 6 (1985) 199-211
8. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 320 (1989) 618-627
9. Roberts R., Rogers W.J., Mueller H.S., Lambrew C.T., Diver D.J., Smith H.C., Willerson J.T., Knatterud G.L., Forman S., and Passamani E. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B study. Circulation 83 (1991) 422-437
10. Gheorghiade M., and Goldstein S. Beta-blockers in the post-myocardial infarction patient. Circulation 106 (2002) 394-398
11. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
12. Goldberg R.J., Spencer F.A., Steg P.G., Flather M., Montalescot G., Gurfinkel E.P., Kennelly B.M., Goodman S.G., Dedrick R., and Gore J.M. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Arch Intern Med 167 (2007) 1766-1773
13. Krumholz H.M., Radford M.J., Wang Y., Chen J., and Marciniak T.A. Early beta-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med 131 (1999) 648-654
14. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., Smith Jr. S.C., Alpert S.S., Anderson J.L., Faxon D.P., Fuster V., Gibbons R.J., Gregoratos G., Halperin J.L., Hiratzka L.F., Hunt S.A., and Jacobs A.K. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Practice guidelines. J Am Coll Cardiol 44 (2004) e1-e211
15. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., Chavey II W.E., Fesmire F.M., Hochman J.S., Levin T.N., Lincoff A.M., Peterson E.D., Theroux P., Wenger N.K., Wright R.S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Halperin J.L., Hunt S.A., Krumholz H.M., Kushner F.G., Lytle B.W., Nishimura R., and Ornato J.P. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Practice guidelines. J Am Coll Cardiol 50 (2007) e1-e157
16. Krumholz H.M., Anderson J.L., Bachelder B.L., Fesmire F.M., Fihn S.D., Foody J.M., Ho P.M., Kosiborod M.N., Masoudi F.A., and Nallamothu B.K. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Performance Measures. J Am Coll Cardiol 52 (2008) 2046-2099
17. Chen Z.M., Pan H.C., Chen Y.P., Peto R., Collins R., Jiang L.X., Xie J.X., and Liu L.S. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
18. Setoguchi S., Glynn R.J., Avorn J., Levin R., and Winkelmayer W.C. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or = 65 years of age. Am J Cardiol 100 (2007) 1061-1067
19. Vega D.D., Dolan K.L., and Pollack M.L. Beta-blocker use in elderly ED patients with acute myocardial infarction. Am J Emerg Med 24 (2006) 435-439
20. Alexander K.P., Newby L.K., Armstrong P.W., Cannon C.P., Gibler W.B., Rich M.W., Van de Werf F., White H.D., Weaver W.D., Naylor M.D., Gore J.M., Krumholz H.M., and Ohman E.M. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the AHA Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115 (2007) 2570-2589
21. Skolnick A.H., Alexander K.P., Chen A.Y., Roe M.T., Pollack Jr. C.V., Ohman E.M., Rumsfeld J.S., Gibler W.B., Peterson E.D., and Cohen D.J. Characteristics, management, and outcomes of 5,557 patients age > or = 90 years with acute coronary syndromes: results from the CRUSADE initiative. J Am Coll Cardiol 49 (2007) 1790-1797